Abu Dhabi, United Arab Emirates
Joined January 2013
- Tweets430
- Following703
- Followers1K
- Likes1K
Stephen Grobmyer retweeted
This Breast Cancer Awareness Month, we celebrate the patients, families, caregivers, and healthcare professionals who face breast cancer with courage and determination every day.
We are fortunate to work in a world-class breast cancer program committed to one mission: putting patients first. Proud to be part of this team. 💗 @ClevelandClinic @AmandaMaggiotto
#BreastCancerAwarenessMonth #PatientFirst #ClevelandClinic #BreastCancerCare
Stephen Grobmyer retweeted
Ranked #1 in the Middle East, we set the standard for healthcare in the region, time and again.
Stephen Grobmyer retweeted
Hosted by the U.S.–UAE Business Council, we were pleased to take part in an insightful workshop at the World Health Expo 2026. The sessions explored the UAE’s continued shift toward preventive and patient-focused healthcare.
Dr. Stephen Grobmyer, joined the discussion, highlighting the importance of collaboration and innovation in shaping more resilient healthcare systems.
Stephen Grobmyer retweeted
Advancing access to #genetherapy where patients live matters.
Looking forward to being @CCAD on Feb 11–12 to discuss and screen patients with# sicklecell disease and #thalassemia and to help deliver this transformative care closer to home in the UAE.
linkedin.com/posts/cleveland…
Stephen Grobmyer retweeted
Honored to give Grand Rounds on Invasive Lobular Carcinoma at @CleClinicAbuDhabi. Truly blown away by the excellence, innovation, and level of oncology care in Abu Dhabi.
Grateful to Dr. #Bassel_Jallad and Dr. @grobmys for the warm welcome and inspiring leadership. 🌍✨
Stephen Grobmyer retweeted
From day one, Mark Ulrich helped shape the five-star patient and family experience we’re known for today.
As one of our founding caregivers and Senior Director of Patient Support Services, he reflects on 10 years of building a culture rooted in compassion, professionalism, and hospitality at Cleveland Clinic Abu Dhabi.
Stephen Grobmyer retweeted
Investors cheered strong earnings reports and news of more trade agreements. Chief Investment Officer Brent Schutte looks at how the levies may add to economic bifurcation and why companies may change tactics in dealing with rising import costs. northwesternmutual.com/life-…
Stephen Grobmyer retweeted
Leptomenigeal disease is one of the toughest diagnosis to treat! This is promising - but early !
HER3-targeted patritumab deruxtecan showed efficacy in leptomeningeal metastases from solid tumors in the Phase II TUXEDO-3 trial
📈 65% 3-month survival
🧬 Activity in intracranial lesions
🔷 From Matthias Preusser, MD, et al in
@NatureMedicine
🔗 ascopost.com/news/july-2025/…
Stephen Grobmyer retweeted
Minimizing Toxicity From Chemotherapy in Early-Stage Testicular Cancer | @JCOOP_ASCO ascopubs.org/doi/10.1200/OP-… Thank you @ChrisWeeMD @CleClinicMD @CCF_IMCHIEFS For the excellent review @OncoAlert
Stephen Grobmyer retweeted
From diagnosis and 'tumor board' meetings, to treatment, #ClevelandClinicAbuDhabi comprehensive Lung Cancer Program is the most advanced in the region, with a course of action for every scenario. So let’s walk you through it now.
Watch the full video to learn more.
Happy Wednesday
Great team of teams doing incredible work together to help our patients
@CCAD
Stephen Grobmyer retweeted
Congrats! Important work
An Editor's Pick paper at @jbiolchem! Don't forget to read the profile about the first author @li_xiuxiu_ at the end of our paper on HSD3B1 and breast cancer! Dr. Li recently moved from @dsui_miami_uro and @SylvesterCancer to @ONealCancerUAB sciencedirect.com/science/ar…
Stephen Grobmyer retweeted
The @ASCOPost spotlights the career of @grobmys in conversation with @jamecancerdoc. From Cleveland to Abu Dhabi, he has advanced #GlobalOncology by building programs and elevating care across borders. 🌍
Read all about Stephen R. Grobmyer, MD here: ascopost.com/issues/june-25-…
Stephen Grobmyer retweeted
In patients with locally advanced hepatocellular carcinoma, stereotactic body radiation therapy (SBRT) combined with sorafenib improved progression-free survival and showed a clinically important improvement in overall survival compared to sorafenib alone. ja.ma/3VKXCQl
We are very excited to announce plans to move forward with Heavy Ion Program at Cleveland Clinic Abu Dhabi - Fatima bint Mubarak Center. Our new center will be 1 of 15 in the world and 1 of only 8 outside of Japan. #patientsfirst
Proud to work at this great hospital which is about to celebrate 10th Anniversary and has recently been voted number #1 Hospital in UAE and in top 200 in the world by Newsweek! #clevelandclinicabudhabi
